Hariharan Sundaram, McBride Maureen A, Cherikh Wida S, Tolleris Christine B, Bresnahan Barbara A, Johnson Christopher P
Division of Nephrology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
Kidney Int. 2002 Jul;62(1):311-8. doi: 10.1046/j.1523-1755.2002.00424.x.
Improvements in long-term kidney graft survival have been recently noted. However, the reasons for this were unclear. This study examined post-transplant renal function within the first year as an independent variable influencing long-term survival.
The influence of demographic characteristics (age, sex, race); transplant variables (cadaver versus living donor, cold ischemia time, HLA mismatching, delayed graft function and transplant year), and post-transplant variables (immunosuppressive agents for the prevention of acute rejection, clinical acute rejection and post-transplant renal function in the first year) on graft survival were analyzed for 105,742 adult renal transplants between 1988 and 1998. Renal function in the first year was expressed as serum creatinine at six months and one year and delta creatinine (change in serum creatinine between 6 months and 1 year). Graft half-life was used to measure long-term survival.
During this 11-year period, the one-year serum creatinine values for cadaver recipients steadily improved, from 1.82 +/- 0.82 mg/dL in 1988 to 1.67 +/- 0.82 mg/dL in 1998 (P < 0.001), as did the graft half-life. There was a progressive decline in graft half-life for each incremental increase of six month, one year and Delta creatinine for living and cadaver donor transplants as well for cadaver transplants with donor age > and < or =50 years. The Relative Hazard (RH) for graft failure was 1.63 (1.61, 1.65; P < 0.0001) with each increment of 1.0 mg/dL of serum creatinine at one year post-transplant and it increased to 2.26 (2.2, 2.31; P < 0.0001) when the Delta creatinine was 0.5 mg/dL. The RH reduction for graft failure was substantially lower for the years 1993, 1996, 1997 and 1998 when post-transplant renal function was not included in the model (P < 0.05). However, the RH reduction per year was not different when post-transplant creatinine was included in the model, 1.01 (0.94 to 1.05; P = 0.89).
In conclusion, one-year creatinine and Delta creatinine values predict long-term renal graft survival. Recent improvements in graft half-life are related to conservation of renal function within the first year post-transplantation.
近期发现长期肾移植存活率有所提高。然而,其原因尚不清楚。本研究将移植后第一年的肾功能作为影响长期存活的一个独立变量进行了研究。
分析了1988年至1998年间105742例成人肾移植受者的人口统计学特征(年龄、性别、种族)、移植变量(尸体供肾与活体供肾、冷缺血时间、HLA配型不符、移植肾功能延迟恢复及移植年份)以及移植后变量(预防急性排斥反应的免疫抑制剂、临床急性排斥反应及移植后第一年的肾功能)对移植肾存活的影响。第一年的肾功能用6个月和1年时的血清肌酐以及肌酐变化值(6个月至1年血清肌酐的变化)来表示。移植肾半衰期用于衡量长期存活情况。
在这11年期间,尸体供肾受者的1年血清肌酐值稳步改善,从1988年的1.82±0.82mg/dL降至1998年的1.67±0.82mg/dL(P<0.001),移植肾半衰期也有改善。对于活体供肾和尸体供肾移植,以及供者年龄>50岁和≤50岁的尸体供肾移植,随着6个月、1年及肌酐变化值每增加一个单位,移植肾半衰期呈逐渐下降趋势。移植后1年血清肌酐每增加1.0mg/dL,移植肾失功的相对风险(RH)为1.63(1.61,1.65;P<0.0001),当肌酐变化值为0.5mg/dL时,RH增加至2.26(2.2,2.31;P<0.0001)。在1993年、1996年、1997年和1998年,当模型中未纳入移植后肾功能时,移植肾失功的RH降低幅度显著较低(P<0.05)。然而,当模型中纳入移植后肌酐时,每年的RH降低幅度无差异,为1.01(0.94至1.05;P=0.89)。
总之,1年时的肌酐值和肌酐变化值可预测肾移植的长期存活情况。近期移植肾半衰期的改善与移植后第一年肾功能的保存有关。